Acurx pharmaceuticals to present at the h.c. wainwright 25th annual global investment conference september 11-13, 2023

Staten island, n.y. , aug. 22, 2023 /prnewswire/ -- acurx pharmaceuticals, inc. (nasdaq: acxp) ("acurx" or the "company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today that david p.

ACXP Ratings Summary

ACXP Quant Ranking